# Camrelizumab plus carboplatin and pemetrexed versus chemotherapy alone in chemotherapy-naive patients with advanced non-squamous non-small-cell lung cancer (CameL): a randomised, open-label, multicentre, phase 3 trial

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/camrelizumab-plus-carboplatin-and-pemetrexed-versus-chemotherapy-alone-in/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Caicun Zhou,Gongyan Chen,Yunchao Huang,Jianying Zhou,Lizhu Lin,Jifeng Feng,Zhehai Wang,Yongqian Shu,Jianhua Shi,Yi Hu,Qiming Wang,Ying Cheng,Fengying Wu,Jianhua Chen,Xiaoyan Lin,Yongsheng Wang,Jianan Huang,Jiuwei Cui,Lejie Cao,Yunpeng Liu,Yiping Zhang,Yueyin Pan,Jun Zhao,Liping Wang,Jianhua Chang,Qun Chen,Xiubao Ren,Wei Zhang,Yun Fan,Zhiyong He,Jian Fang,Kangsheng Gu,Xiaorong Dong,Tao Zhang,Wei Shi,Jianjun Zou |
| Citations | 508 |
| DOI | 10.1016/s2213-2600(20)30365-9 |
| Fields | Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W3111665711 |
| PMID | 33347829 |
| Type | article |
| Year | 2020 |

## Paper authors

- [Yueyin Pan](https://scholariq.org/researchers/yueyin-pan/)
- [Ying Cheng](https://scholariq.org/researchers/ying-cheng/)
- [Xiubao Ren](https://scholariq.org/researchers/xiubao-ren/)

## Paper journal

- [The Lancet Respiratory Medicine](https://scholariq.org/journals/the-lancet-respiratory-medicine/)

## Paper primary topic

- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)

## Paper topics

- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Lung Cancer Diagnosis and Treatment](https://scholariq.org/topics/lung-cancer-diagnosis-and-treatment/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.